Sanofi SA (NASDAQ:SNY)
| 46.35 BATS BZX Real-Time Price As of 10:26am ET |  -0.245 / -0.53%Today’s Change | 42.63 Today|||52-Week Range 57.82 | -4.29% Year-to-Date |
Latest SNY News | Press Releases
| 2 Biotech Stocks You Can Buy and Hold for the Next Decade 8:30am / MotleyFool.com - Paid Partner Content | Teva Pharmaceutical: Long-Term Cash Cow Nov 27 / GuruFocus News - Paid Partner Content |
| Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study Nov 27 / Zacks.com - Paid Partner Content | Regeneron (REGN) Stock Rallies 10% YTD: What Lies Ahead? Nov 24 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 46.60 |
| Today’s open | 46.12 |
| Day’s range | 46.00 - 46.35 |
| Volume | 17,941 |
| Average volume (3 months) | 1,826,545 |
| Market cap | $117.1B |
Data as of 10:26am ET, 11/30/2023
Growth & Valuation
| Earnings growth (last year) | +19.66% |
| Earnings growth (this year) | +0.91% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +1.25% |
| P/E ratio | 11.8 |
| Price/Sales | 2.69 |
| Price/Book | 1.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BMYBristol-Myers Squibb | -0.10 | -0.21% |
| VRTXVertex Pharmaceutica... | +2.18 | +0.62% |
| REGNRegeneron Pharmaceut... | +11.81 | +1.46% |
| ZTSZoetis Inc | -1.66 | -0.94% |
Data as of 10:26am ET, 11/30/2023
Financials
| Next reporting date | February 1, 2024 |
| EPS forecast (this quarter) | $0.95 |
| Annual revenue (last year) | $45.2B |
| Annual profit (last year) | $8.8B |
| Net profit margin | 19.47% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
